Clinical Physiology, Department of Clinical Sciences Lund Lund University, Skåne University Hospital Lund Sweden.
J Am Heart Assoc. 2023 May 2;12(9):e028313. doi: 10.1161/JAHA.122.028313. Epub 2023 Apr 29.
Background Both myocardial perfusion single-photon emission computed tomography (MPS) and exercise ECG (Ex-ECG) carry prognostic information in patients with stable chest pain. However, it is not fully understood if combining the findings of MPS and Ex-ECG improves risk prediction. Current guidelines no longer recommend Ex-ECG for diagnostic evaluation of chronic coronary syndrome, but Ex-ECG could still be of incremental prognostic importance. Methods and Results This study comprised 908 consecutive patients (age 63.3±9.4 years, 49% male) who performed MPS with Ex-ECG. Subjects were followed for 5 years. The end point was a composite of cardiovascular death, acute myocardial infarction, unstable angina, and unplanned percutaneous coronary intervention. National registry data and medical charts were used for end point allocation. Combining the findings of MPS and Ex-ECG resulted in concordant evidence of ischemia in 72 patients or absence of ischemia in 634 patients. Discordant results were found in 202 patients (MPS-/Ex-ECG+, n=126 and MPS+/Ex-ECG-, n=76). During follow-up, 95 events occurred. Annualized event rates significantly increased across groups (MPS-/Ex-ECG- =1.3%, MPS-/Ex-ECG+ =3.0%, MPS+/Ex-ECG- =5.1% and MPS+/Ex-ECG+ =8.0%). In multivariable analyses MPS was the strongest predictor regardless of Ex-ECG findings (MPS+/Ex-ECG-, hazard ratio [HR], 3.0, =0.001 or MPS+/Ex-ECG+, HR,4.0, <0.001). However, an abnormal Ex-ECG almost doubled the risk in subjects with normal MPS (MPS-/Ex-ECG+, HR, 1.9, =0.04). Conclusions In patients with chronic coronary syndrome, combining the results from MPS and Ex-ECG led to improved risk prediction. Even though MPS is the stronger predictor, there is an incremental value of adding data from Ex-ECG to MPS, especially in patients with normal MPS.
心肌灌注单光子发射计算机断层扫描(MPS)和运动心电图(Ex-ECG)均可为稳定型胸痛患者提供预后信息。然而,目前尚不完全清楚联合 MPS 和 Ex-ECG 的检查结果是否可以改善风险预测。目前的指南不再推荐 Ex-ECG 用于慢性冠状动脉综合征的诊断评估,但 Ex-ECG 可能仍然具有重要的预后价值。
本研究纳入了 908 例连续接受 MPS 联合 Ex-ECG 检查的患者(年龄 63.3±9.4 岁,49%为男性)。对这些患者进行了 5 年的随访。终点是心血管死亡、急性心肌梗死、不稳定型心绞痛和计划外经皮冠状动脉介入治疗的复合终点。使用国家登记数据和病历进行终点分配。联合 MPS 和 Ex-ECG 的检查结果发现,72 例患者存在缺血,634 例患者无缺血,202 例患者的结果不一致(MPS-/Ex-ECG+,n=126;MPS+/Ex-ECG-,n=76)。随访期间共发生 95 例事件。各组的年化事件发生率显著增加(MPS-/Ex-ECG- =1.3%,MPS-/Ex-ECG+ =3.0%,MPS+/Ex-ECG- =5.1%,MPS+/Ex-ECG+ =8.0%)。多变量分析显示,无论 Ex-ECG 检查结果如何,MPS 都是最强的预测因素(MPS+/Ex-ECG-,危险比[HR],3.0,=0.001;MPS+/Ex-ECG+,HR,4.0,<0.001)。然而,在 MPS 正常的患者中,异常的 Ex-ECG 使风险几乎增加了一倍(MPS-/Ex-ECG+,HR,1.9,=0.04)。
在慢性冠状动脉综合征患者中,联合 MPS 和 Ex-ECG 的检查结果可以改善风险预测。尽管 MPS 是更强的预测因素,但将 Ex-ECG 的数据添加到 MPS 中具有额外的价值,尤其是在 MPS 正常的患者中。